With the most scientifically validated technology platform in the breast health industry, Volpara is the preferred partner of leading clinical sites around the world.
VolparaEnterprise software provides ConstantQuality metrics and breast-specific key performance indicators to help your team perform at its very best, delivering the highest-quality breast imaging services.
Volpara Health is the wholly owned sales and marketing arm of Volpara Health Technologies Limited—an ISO13485- and ISO27001-certified, ISO14971- and FDA GMP–compliant research, development, and manufacturing company that develops digital health solutions to enable personalized, high-quality breast cancer screening based on objective measurements of breast density, compression, and radiation dose.
Volpara is the tool of choice for many researchers around the world. The Volpara suite of products provides ongoing information for improving clinical screening to population characteristics and breast cancer risk.